The most studied is the FGFR-Klotho axis, and Klotho could act as cofactor of endocrine FGFs to bind and induce the activation of FGFRs in breast, pancreatic, and prostate cancers [11, 30, 44]. This evidence concerns the gene KL and prostate carcinoma.